False-positive results in clinical trials: Multiple significance tests and the problem of unreported comparisons

Journal of the National Cancer Institute

Volumn 88, Issue 3-4, 1996, Pages 206-207

  Tannock, Ian F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; LABORATORY DIAGNOSIS; PROBABILITY; STATISTICAL ANALYSIS;

CLINICAL TRIALS; HUMANS; PUBLISHING; RANDOMIZED CONTROLLED TRIALS; STATISTICS;

EID: 0030024848     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.3-4.206     Document Type: Article

References (9)

1. Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986;4:1529-41.
2. Begg CB, Berlin JA. Publication bias and dissemination of clinical research J Natl Cancer Inst 1989;81:107-15.
3. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research [see comment citation(s) in Medline]. Lancet 1991;337:867-72.
4. De Bellefeuille C, Morrison CA, Tannock IF. The fate of abstracts submitted to a cancer meeting: factors which influence presentation and subsequent publication. Ann Oncol 1992;3:187-91
5. Chlebowski RT, Lillington LM. A decade of breast cancer clinical investigation, results as reported in the Program/Proceedings of the American Society of Clinical Oncology [see comment citations in Medline]. J Clin Oncol 1994;12:1789-95.
6. Staquet MJ, Rozencweig M, Von Hoff DD, Muggia FM. The delta and epsilon errors in the assessment of cancer clinical trials. Cancer Treat Rep 1979;63:1917-21.
7. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med 1987,317:426-32.
8. Pocock SJ, Geller NL, Tsiatis AA. The analysis of multiple endpoints in clinical trials [see comment citation in Medline]. Biometrics 1987;43:487-98.
9. Rothman KJ. No adjustments are needed for multiple comparisons Epidemiology 1990,1: 43-6.